The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. One research ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

Jack Hoffman died at the age of 19, following a long battle with brain cancer. He was the face of the Team Jack Foundation, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

Vivesto AB, an oncology-focused development company, today announced that ethical approval has been obtained from the US Veterinary Review Board Clinical Studies Committee ...

Experts reveal why cancer is surging more in women than menThe face of cancer in the US is shifting from older to younger ...

Of note, prostate adenocarcinoma with “treatment effect” is not ... systematic/targeted biopsy, and post surgery tumor maps. 1 The primary outcome was the ability of clinicopathologic and imaging ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its Optilume® Drug-Coated Balloon (DCB). The ...